Geisinger Partners with Indivumed for Personalized Medicine Initiative - Newswise Newswise (press release) Indivumed follows highly standardized processes that enable the company to limit cold ischemia time – the time between removal of tissue from the body and the time it is preserved – to less than 10 minutes, guaranteeing tissue samples maintain their ... |
